DIA 48th Annual Meeting
Click here to go to the previous page
Environment for Health Care Decision Making: The Role of CER, Evidence-based Medicine, Quality, and Value
Track
:
Track 13: Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)/Health Technology Assessment (HTA)
Program Code:
319
Date:
Wednesday, June 27, 2012
Time:
8:00 AM to 9:30 AM
EST
CHAIR
:
Kimberly Westrich, National Pharmaceutical Council, United States
PRESENTER
(S):
Kimberly Westrich, National Pharmaceutical Council, United States Nader Halim, Quintiles, United States
J. Sanford Schwartz, University of Pennsylvania, United States
Description
This session will provide an overview of the role of comparative effectiveness research (CER) in the current environment for health care decision making. Specific components will include the results of two rounds of surveys of health care influentials on the state of the environment for health care decisions, good practice principles for CER, and case studies focusing on the synergy between CER and quality measures.
Learning Objectives:
Describe the state of CER, its use, and impact
Identify future effects of CER on health care decision making
Discuss key issues related to the future of CER, application of evidence, and impact on decision making Describe the role of quality and value in health care decision making environment.
Learning Objectives:
Describe the state of CER, its use, and impact
Identify future effects of CER on health care decision making
Discuss key issues related to the future of CER, application of evidence, and impact on decision making Describe the role of quality and value in health care decision making environment.
This session is a part of:
Handout Online
